Mark S. Graham

Array ( [id] => 6024254 [patent_doc_number] => 20110052580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'USE OF PICOPLATIN AND BEVACIZUMAB TO TREAT COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/866702 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8914 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052580.pdf [firstpage_image] =>[orig_patent_app_number] => 12866702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228893 [patent_doc_number] => 20100183631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Antibodies Directed to HER-3 and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/365784 [patent_app_country] => US [patent_app_date] => 2009-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 27932 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12365784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479589 [patent_doc_number] => 20090202546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF' [patent_app_type] => utility [patent_app_number] => 12/361180 [patent_app_country] => US [patent_app_date] => 2009-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 25873 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202546.pdf [firstpage_image] =>[orig_patent_app_number] => 12361180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5302857 [patent_doc_number] => 20090297509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-03 [patent_title] => 'Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases' [patent_app_type] => utility [patent_app_number] => 12/321948 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5516 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20090297509.pdf [firstpage_image] =>[orig_patent_app_number] => 12321948 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 92553 [patent_doc_number] => 07732588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-08 [patent_title] => 'Tweak receptor' [patent_app_type] => utility [patent_app_number] => 12/355729 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19508 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/732/07732588.pdf [firstpage_image] =>[orig_patent_app_number] => 12355729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6489008 [patent_doc_number] => 20100009437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Isolated proteins MAGE-4 and MAGE-41' [patent_app_type] => utility [patent_app_number] => 12/319796 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16457 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009437.pdf [firstpage_image] =>[orig_patent_app_number] => 12319796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9875537 [patent_doc_number] => 08962806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-24 [patent_title] => 'Humanized monoclonal antibodies and methods of use' [patent_app_type] => utility [patent_app_number] => 12/810888 [patent_app_country] => US [patent_app_date] => 2008-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 27822 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12810888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159545 [patent_doc_number] => 20110158988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-30 [patent_title] => 'ANTIBODIES AGAINST EXTRACELLULAR DOMAINS 2 AND 3 OR HER2' [patent_app_type] => utility [patent_app_number] => 12/997823 [patent_app_country] => US [patent_app_date] => 2008-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18502 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20110158988.pdf [firstpage_image] =>[orig_patent_app_number] => 12997823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324216 [patent_doc_number] => 20090062206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Urodilatin Cancer Treatment' [patent_app_type] => utility [patent_app_number] => 12/264997 [patent_app_country] => US [patent_app_date] => 2008-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6883 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062206.pdf [firstpage_image] =>[orig_patent_app_number] => 12264997 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5367031 [patent_doc_number] => 20090304590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Therapeutic compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/290176 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 128 [patent_figures_cnt] => 128 [patent_no_of_words] => 48793 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304590.pdf [firstpage_image] =>[orig_patent_app_number] => 12290176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5428122 [patent_doc_number] => 20090087432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-02 [patent_title] => 'TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/247850 [patent_app_country] => US [patent_app_date] => 2008-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 31660 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20090087432.pdf [firstpage_image] =>[orig_patent_app_number] => 12247850 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5563636 [patent_doc_number] => 20090136488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Inhibition of cancer metastasis' [patent_app_type] => utility [patent_app_number] => 12/286950 [patent_app_country] => US [patent_app_date] => 2008-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 16531 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136488.pdf [firstpage_image] =>[orig_patent_app_number] => 12286950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480090 [patent_doc_number] => 20090203047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => '88kDa tumorigenic growth factor and antagonists' [patent_app_type] => utility [patent_app_number] => 12/239392 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 18997 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203047.pdf [firstpage_image] =>[orig_patent_app_number] => 12239392 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5322936 [patent_doc_number] => 20090060926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'MEDICINE FOR TREATMENT OF CARCINOMA' [patent_app_type] => utility [patent_app_number] => 12/203204 [patent_app_country] => US [patent_app_date] => 2008-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2159 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060926.pdf [firstpage_image] =>[orig_patent_app_number] => 12203204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5452062 [patent_doc_number] => 20090068099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'CANCEROUS DISEASE MODIFYING ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/196350 [patent_app_country] => US [patent_app_date] => 2008-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13449 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068099.pdf [firstpage_image] =>[orig_patent_app_number] => 12196350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066191 [patent_doc_number] => 20110243927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'METHODS OF INHIBITING TUMOR GROWTH USING BETA 5 INTEGRIN ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 12/674300 [patent_app_country] => US [patent_app_date] => 2008-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13831 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243927.pdf [firstpage_image] =>[orig_patent_app_number] => 12674300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8549062 [patent_doc_number] => 08323943 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-04 [patent_title] => 'Screening method for anticancer drug' [patent_app_type] => utility [patent_app_number] => 12/191049 [patent_app_country] => US [patent_app_date] => 2008-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6053 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12191049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9977043 [patent_doc_number] => 09023350 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Synergistic pharmaceutical composition useful for inhibiting corneal and retinal neovascularization (angiogenesis), and in other organs, in a human being or animals' [patent_app_type] => utility [patent_app_number] => 12/735659 [patent_app_country] => US [patent_app_date] => 2008-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4341 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12735659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7499419 [patent_doc_number] => 20110262430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'NOVEL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/671607 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 30892 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262430.pdf [firstpage_image] =>[orig_patent_app_number] => 12671607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6081418 [patent_doc_number] => 20110143351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'GLYOSYLATION MARKERS FOR CANCER AND CHRONIC INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/452720 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 30458 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20110143351.pdf [firstpage_image] =>[orig_patent_app_number] => 12452720 [rel_patent_id] =>[rel_patent_doc_number] =>)